News

Filter

Current filters:

None

Popular Filters

8020 to 8044 of 8448 results

Watson to invest $44 million in R&D and manufacturing plant expansion

23-06-2011

US branded and generics drugmaker Watson Pharmaceuticals (NYSE: WPI) says it is investing around $44…

FinancialGenericsLidodermNeurologicalPfizerWatson Pharmaceuticals

Jubilant and AstraZeneca successful in delivery of early milestones in pain drug accord

23-06-2011

Jubilant Biosys, a Bengaluru-based subsidiary of India’s Jubilant Life Sciences, and Anglo-Swedish…

AstraZenecaCardio-vascularJubilantMetabolicsNeurologicalPharmaceuticalResearch

India tells UN meeting it will not accept data exclusivity as part of FTA with EU

23-06-2011

India formally announced at the UN High Level Meeting on HIV and AIDS held in New York, USA, earlier…

Asia-PacificEuropeGenericsPatentsPharmaceuticalPolitics

CSL Biotherapies gets official warning letter from US FDA

23-06-2011

The US Food and Drug Administration issued a formal warning letter to Australia’s largest biotech…

AfluriaAsia-PacificBiotechnologyCSL BiotherapiesCSL LimitedNorth AmericaRegulationVaccines

Merck KGaA drops plans for oral MS drug cladribine, leaving field clear for Gilenya

23-06-2011

German drug major Merck KGaA (MRK: DE) said yesterday that, following feedback from regulatory authorities,…

CladribineGilenyaMarkets & MarketingMerck KGaANeurologicalNovartisPharmaceuticalRegulation

EU clears anti-JC virus risk labeling for Biogen and Elan’s Tysabri

23-06-2011

US biotech firm Biogen Idec (Nasdaq: BIIB) and Ireland-based Elan (NYSE: ELN) said yesterday that the…

Biogen IdecBiotechnologyElanEuropeNeurologicalRegulationTysabri

Johnson & Johnson invests $30 million in deal with Russia’s Skolkovo

23-06-2011

US health care giant Johnson & Johnson (NYSE: JNJ), together with its pharmaceutical division Janssen…

Anti-viralsEuropeFinancialJanssen PharmaceuticaJohnson & JohnsonOncologyPharmaceuticalResearch

Roche to start production of Herceptin in Russia

23-06-2011

R-Farm, one of Russia’s largest drugs’ distributors, has reached an agreement with Roche (ROG:…

EuropeHerceptinLicensingMarkets & MarketingOncologyPharmaceuticalR-FarmRoche

US FDA approves ProStrakan’s Rectiv for anal fissures pain

22-06-2011

Scotland-based ProStrakan, now a subsidiary of Japan’s Kyowa Hakko Kirin (TYO: 4151) as the result…

Gastro-intestinalsKyowa Hakko KirinNorth AmericaPharmaceuticalProStrakanRectivRectogesicRegulation

EU generic drugmakers launch code of conduct on MAA slots

22-06-2011

The European Generic medicines Association (EGA) says it has officially launched a code of conduct on…

EuropeGenericsRegulation

Canada’s PMPRB reports slow-down in pharma sales

22-06-2011

In its annual report for 2010 released to Canada’s Parliament last week, the Patented Medicine Prices…

GenericsMarkets & MarketingNorth AmericaPatentsPharmaceuticalPoliticsPricing

Eli Lilly gets EU approval for long-acting diabetes drug Bydureon

22-06-2011

In what was excellent news for all three companies following rejections of the drug by US regulators,…

AlkermesAmylinBydureonDiabetesEli LillyEuropePharmaceuticalRegulation

Rise in M&A for China's pharmaceutical sector forecast by KPMG

22-06-2011

Both multinationals drugmakers and large domestic players are set to grab a larger share of the pharmaceutical…

Asia-PacificGenericsHealthcareMergers & AcquisitionsPharmaceutical

Novo Nordisk invests $190 million in new Danish plant, AstraZeneca sells Astra Tech

22-06-2011

Danish insulin giant Novo Nordisk (NVO: N) said this morning that it is investing close to 1 billion…

AstraZenecaFinancialMergers & AcquisitionsNovo NordiskPharmaceutical

Positive mid-stage data on Roche and Curis' BCC drug vismodegib

22-06-2011

Swiss drug major Roche (ROG: SIX) yesterday reported positive results from a mid-stage trial on vismodegib…

CurisOncologyPharmaceuticalResearchRochevismodegib

Pfizer’s Lyrica meets endpoint in Ph III study of central neuropathic pain after spinal cord injury

22-06-2011

Global drugs behemoth Pfizer (NYSE: PFE) says its blockbuster neuropathic pain drug Lyrica (pregabalin)…

LyricaNeurologicalPfizerPharmaceuticalRegulation

US FDA views ways to improve consumer understanding of Rx drug ads

21-06-2011

Findings from three studies conducted by the US Food and Drug Administration confirm that the way information…

Markets & MarketingNorth AmericaPharmaceuticalRegulation

Joint ventures in generics to boost Indian pharma industry

21-06-2011

The Indian pharmaceutical industry is moving towards the adoption and development of generic drugs, which…

Asia-PacificGenericsMarkets & MarketingMergers & Acquisitions

Indonesia MoH and PFCD address challenges posed by chronic NCDs

21-06-2011

The Indonesia Ministry of Health and the Partnership to Fight Chronic Disease (PFCD: a USA-based non-governmental…

Asia-PacificHealthcarePharmaceutical

Australia and New Zealand resurrect plans for joint Therapeutic Products Agency; Medicines Australia views impact

21-06-2011

The governments of Australian and New Zealand have agreed to proceed with a joint scheme for regulation…

Asia-PacificPharmaceuticalRegulation

Pfizer and Acura’s tamper resistant opioid Oxecta gets US FDA approval

21-06-2011

After a significant delay, drugs behemoth Pfizer (NYSE: PFE) and partner Acura Pharmaceuticals (Nasdaq:…

Acura PharmaceuticalsNeurologicalNorth AmericaOxectaPfizerPharmaceuticalRegulationRemoxy

8020 to 8044 of 8448 results

Back to top